Bharathi Upadhya, MD

Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan

08/01/2008

Robert J. Applegate , MD;

Sanjay K. Gandhi , MD, PhD;

Michael A. Kutcher , MD, FACC, FSCAI;

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

08/01/2008

Michael A. Kutcher , MD, FACC, FSCAI;

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Robert J. Applegate , MD;

Sanjay K. Gandhi , MD, PhD;

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology